Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia

被引:73
作者
Elfgren, K
Jacobs, M
Walboomers, JMM
Meijer, CJLM
Dillner, J
机构
[1] Huddinge Univ Hosp, Dept Obstet & Gynecol, Karolinska Inst, Dept Obstet & Gynecol, S-14186 Huddinge, Sweden
[2] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
[3] Malmo Univ Hosp, Dept Med Virol, Malmo, Sweden
[4] Vrije Univ Amsterdam, Univ Hosp, Dept Pathol, Amsterdam, Netherlands
关键词
D O I
10.1016/S0029-7844(02)02280-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To investigate the rate of clearance of human papillomavirus (HPV) infection after surgical treatment for cervical intraepithelial neoplasia (CIN). METHODS: One hundred nine women with CIN I-III, treated with cryosurgery or conization at a university hospital, were observed with cervical HPV deoxyribonucleic acid (DNA) testing by general primer polymerase chain reaction and HPV typing at 0, 3, 6, 9, 12, and 24 months after treatment. Penile HPV DNA was analyzed from current sexual partners. RESULTS: Eighty-one percent of evaluable women were HPV DNA positive at treatment or enrollment. One year later, seven women (9%) remained positive for the same HPV type. Most women had cleared the HPV infection diagnosed at treatment within 3 months. The cryotherapy group had lower CIN grades, was younger, and had a slower HPV clearance rate (P < .002). Only four couples had HPV DNA of the same type detected. CONCLUSION: Surgical treatment of CIN usually results in clearance of HPV infection within 3 months. Human papillomavirus DNA testing may be useful as a rapid intermediate end point for monitoring the efficacy of treatments.
引用
收藏
页码:965 / 971
页数:7
相关论文
共 31 条
  • [1] Anttila A, 1999, INT J CANCER, V83, P59, DOI 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO
  • [2] 2-N
  • [3] Bollen LJM, 1996, CANCER-AM CANCER SOC, V77, P2538, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2538::AID-CNCR17>3.0.CO
  • [4] 2-T
  • [5] Clearance of cervical human papillomavirus infection by treatment for cervical dysplasia
    Bollen, LJM
    TjongAHung, SP
    VanderVelden, J
    Mol, BW
    Boer, K
    TenKate, FJW
    Bleker, OP
    terSchegget, J
    [J]. SEXUALLY TRANSMITTED DISEASES, 1997, 24 (08) : 456 - 460
  • [6] Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri
    Chua, KL
    Hjerpe, A
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 66 (01) : 108 - 113
  • [7] Cervical squamous intraepithelial lesions in HIV-infected women:: prevalence, incidence and regression
    Delmas, MC
    Larsen, C
    van Benthem, B
    Hamers, FF
    Bergeron, C
    Poveda, JD
    Anzén, B
    van den Hoek, A
    Meier, F
    Peña, JM
    Savonius, H
    Sperandeo, D
    Suligoi, B
    Vernazza, P
    Brunet, JB
    De Vincenzi, I
    [J]. AIDS, 2000, 14 (12) : 1775 - 1784
  • [8] Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens
    Elfgren, K
    Bistoletti, P
    Dillner, L
    Walboomers, JMM
    Meijer, CJLM
    Dillner, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (03) : 937 - 942
  • [9] Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison
    Jacobs, MV
    Snijders, PJF
    Voorhorst, FJ
    Dillner, J
    Forslund, O
    Johansson, B
    Doeberitz, MVK
    Meijer, CJLM
    Meyer, T
    Nindl, I
    Pfister, H
    Stockfleth, E
    Strand, A
    Wadell, G
    Walboomers, JMM
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (07) : 498 - 503
  • [10] A general primer GP5+/GP6+-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings
    Jacobs, MV
    Snijders, PJF
    vandenBrule, AJC
    Helmerhorst, TJM
    Meijer, CJLM
    Walboomers, JMM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (03) : 791 - 795